TB vaccine gets its groove back

May 19, 2009

A team of Vanderbilt University Medical Center investigators has cracked one of clinical medicine's enduring mysteries - what happened to the tuberculosis vaccine. The once-effective vaccine no longer prevents the bacterial lung infection that kills more than 1.7 million people worldwide each year.

Their solution, reported in the journal PLoS ONE, could lead to an improved TB vaccine and also may offer a novel platform for vaccines against other pathogens.

"Our findings represent nearly a 180-degree reversal from the dogma of the last 60 years - that the TB vaccine stopped working because it became over-attenuated and was too 'wimpy' to be effective," said Douglas Kernodle, M.D., associate professor of Medicine.

Instead, Kernodle and colleagues found that the TB vaccine has acquired some traits that make it less effective in evoking a sustained immune response. When they take away these traits, the TB vaccine induces stronger immune responses in mice.

The current TB vaccine, known as BCG (bacille Calmette-Guérin), has been around since the 1920s. It was made by weakening (attenuating) a strain of bacteria that causes in cows and that genetically is 98 percent identical to the human TB germ.

During the early years of its use, BCG was 80 percent effective against pulmonary TB. But because there were no long-term storage options for bacterial strains until the 1960s, BCG was grown continuously in culture, with "sub-cultures" of the original BCG maintained in laboratories around the world. Over time, BCG changed - the original vaccine ceased to exist and the daughter sub-cultures lost effectiveness against pulmonary TB.

Today, although BCG no longer protects against lung disease, it is still 80 percent effective against "disseminated TB" (TB infection in many parts of the body) in early childhood. Because of this protection, BCG is given annually to 100 million newborns worldwide - not in the United States and a few other countries - and is estimated to prevent about 40,000 cases each year of TB meningitis and other disseminated TB, Kernodle said.

But the question of why BCG lost its effectiveness against pulmonary TB has not been fully investigated. Researchers accepted the notion that as BCG was grown in culture, it changed genetically and became too weak to evoke the kind of immune response needed for protection.

Kernodle and colleagues came to the problem of BCG's poor activity against pulmonary TB from a different angle. They had reported in 2001 that one way TB itself evades the immune system is by producing antioxidants. Since BCG also produces antioxidants, they suggested that removing BCG's antioxidant-producing capacity might improve the vaccine.

"Our idea to take something away from BCG - and therefore theoretically attenuate it even further - was met with a lot of skepticism," Kernodle said. "But we believed our data that we could make BCG more immunogenic and safer."

Two years ago, after the Kernodle group had modified BCG and was beginning to test it for immune responses, researchers at the Institut Pasteur in Paris published a paper describing the genomic evolution of BCG. They found that in addition to containing gene deletions consistent with attenuation of the vaccine, the BCG genome also had regions of gene duplication and increased gene expression. Some of the duplicated and over-expressed genes were for antioxidants already being targeted by the Kernodle group.

It was suddenly obvious what had happened to BCG, Kernodle said.

"It had not become too weak - instead, by making more antioxidants it had become better at suppressing immune responses."

In the current studies, first author Lakshmi Sadagopal, Ph.D., research instructor of Medicine, vaccinated mice with a modified BCG (genetically changed in three ways to reduce or eliminate the production of several antioxidants) and examined the immune response in the days following vaccination and later with a "challenge" dose of BCG.

She found that, compared to BCG, the modified BCG induced greater cytokine (immune regulatory factor) production during the early phase of the immune response, more CD8 cell-killing T cells at the peak of the primary response, and more CD4 helper T cells during the memory phase. Modified BCG also produced greater recall immune responses and was eliminated better by the vaccinated host animal than the parent BCG vaccine, which might correlate with improved safety in humans.

"At each time point of the immune response, the modified BCG vaccine worked better than the parent BCG vaccine," Kernodle said. "By targeting antioxidants that had increased in expression during decades of cultivation, we ended up making BCG more like it was back in the 1920s when it was 80 percent effective against pulmonary TB. We fixed it."

Using modern molecular techniques to reduce the activity of antioxidants below levels in naturally occurring strains, "it should be possible to make it even better than the original BCG," he added.

The Aeras Global TB Vaccine Foundation, supported by the Bill & Melinda Gates Foundation, has already licensed the modification technology developed by Kernodle and colleagues. Aeras is working to make the best possible modified BCG vaccine, and it has built the infrastructure to conduct clinical trials in South Africa, Kenya and India - countries with a high incidence of TB.

Kernodle and colleagues say the results are also encouraging for other vaccine development. Because the modified BCG produces a better profile than existing technologies, it could be a useful vector for vaccines directed against other pathogens, including HIV and the parasites that cause malaria.

Source: Vanderbilt University Medical Center (news : web)

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Nik_2213
May 19, 2009

Rank: not rated yet
Good !!

I remember getting my BCG 'challenge'-- The site swelled up raw within hours, went down overnight. By the time it was measured, there was nothing. Despite my protests that it had been sore & gone, I was given a large dose of vaccine...

You guessed it-- The site swelled to an agonising egg, ulcerated, wept for weeks. The school's docs could not understand it.

Aware of my fast reaction, when my brother's arm was challenged and swelled, Mum insisted it was checked early, while it was visible.

After some thought, the docs decided (1) that Mum's immunity must have carried over and (2) we'd been 'primed' by recent contact. Yup, one of the teachers was a 'carrier'. And he was a close neighbour, his kids our friends...

FWIW, although I didn't get a secondary infection, and didn't *quite* need a skin graft, I've still got the scar-- And a persistent aversion to needles...

( Despite that, I do get my 'flu, pneumonia, anti-tet etc vaccinations, and recommend them to others. )
Ashy
May 21, 2009

Rank: 1 / 5 (1)
Nik_2213, you are lucky to not have vaccine-associated bone TB, unlike my relative who had bone TB and become invalid after BCG vaccination. You are very lucky.
Rank 4 /5 (4 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Discovery paves way for salmonella vaccine

(Medical Xpress) -- An international research team led by a University of California, Davis, immunologist has taken an important step toward an effective vaccine against salmonella, a group of increasingly antibiotic-resistant ...

Medicine & Health / Research

created 12 minutes ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

First-of-its-kind stem cell study re-grows healthy heart muscle in heart attack patients

Results from a Cedars-Sinai Heart Institute clinical trial show that treating heart attack patients with an infusion of their own heart-derived cells helps damaged hearts re-grow healthy muscle.

Medicine & Health / Cardiology

created 18 minutes ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Ovarian cancer arises in fallopian tube of knockout mice

(Medical Xpress) -- The most deadly form of "ovarian" cancer arises in the fallopian tubes – not the ovaries – of knockout mice that lack two genes associated with the disease, said researchers led by Baylor College ...

Medicine & Health / Cancer

created 13 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Smoking bans lead to less, not more, smoking at home: study

Smoking bans in public/workplaces don't drive smokers to light up more at home, suggests a study of four European countries with smoke free legislation, published online in Tobacco Control.

Medicine & Health / Health

created 18 minutes ago | popularity not rated yet | comments 0

UK cases of progressive sight loss condition set to rise a third by 2020

New cases of the progressive sight loss condition, known as age-related macular degeneration, or AMD for short, are set to rise by a third in the UK over the next decade, reveals research published online in the British Jo ...

Medicine & Health / Diseases

created 17 minutes ago | popularity not rated yet | comments 0


Scientists discover reason for Mt. Hood's non-explosive nature

(PhysOrg.com) -- For a half-million years, Mount Hood has towered over the landscape, but unlike some of its cousins in Oregon’s Cascade Mountains and many other volcanoes around the Pacific “Rim ...

Time of year important in projections of climate change effects on ecosystems

(PhysOrg.com) -- Does it matter whether long periods of hot weather, such as last year's heat wave that gripped the U.S. Midwest, happen in June or July, August or September?

Medical school link to wide variations in pass rate for specialist exam

Wide variations in doctors' pass rates, for a professional exam that is essential for one type of specialty training, seem to be linked to the particular medical school where the student graduated, indicates research published ...

Missing dark matter located: Intergalactic space is filled with dark matter

Researchers at the University of Tokyo’s Institute for the Physics and Mathematics of the Universe (IPMU) and Nagoya University used large-scale computer simulations and recent observational data of gravitational ...

Plants use circadian rhythms to prepare for battle with insects

In a study of the molecular underpinnings of plants' pest resistance, Rice University biologists have shown that plants both anticipate daytime raids by hungry insects and make sophisticated preparations to ...

Sensing self and non-self: New research into immune tolerance

At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually ...